Laddar...
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
We utilized three tiers of screening to identify novel therapeutic agents for pancreatic cancers. First, we analyzed 14 pancreatic cancer cell lines against a panel of 66 small‐molecule kinase inhibitors and dasatinib was the most potent. Second, we performed RNA expression analysis on 3 dasatinib‐r...
Sparad:
I publikationen: | Mol Oncol |
---|---|
Huvudupphovsmän: | , , , , , , , , , , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
John Wiley and Sons Inc.
2015
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387089/ https://ncbi.nlm.nih.gov/pubmed/25637283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.01.002 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|